Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance. Obstructive sleep apnea ...

Medicare drug plans can now cover Eli Lilly's blockbuster obesity drug Zepbound for obstructive sleep apnea, the Centers for Medicare & Medicaid Services confirmed to CNBC. That opens the door for ...

The Food and Drug Administration (FDA) has approved Zepbound to help treat obstructive sleep apnea (OSA ... for certain people with obesity. Medicare Part D prescription drug plans may cover ...

Because it is approved to treat sleep apnea, Medicare covers Zepbound for that purpose. It does not cover it solely for weight loss. Patients paying the list price for the medication would pay about ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the ...

Medicare covers sleep tests when you show clinical signs and symptoms of specific disorders, including sleep apnea, narcolepsy, or parasomnia. Medicare covers different types of sleep studies ...

The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...

In a statement on Thursday, Eli Lilly called Medicare's coverage of Zepbound for the condition ... chronic kidney disease, sleep apnea and more. To be covered, those drugs would need to return ...